BlackRock Health Sciences Term Trust (NYSE:BMEZ) Sees Significant Growth in Short Interest

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a large increase in short interest during the month of March. As of March 13th, there was short interest totaling 36,205 shares, an increase of 188.0% from the February 26th total of 12,573 shares. Based on an average daily trading volume, of 225,332 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily trading volume, of 225,332 shares, the days-to-cover ratio is currently 0.2 days.

BlackRock Health Sciences Term Trust Trading Up 1.5%

BMEZ stock traded up $0.21 during trading hours on Wednesday, hitting $14.02. 309,832 shares of the stock traded hands, compared to its average volume of 283,443. The stock has a 50-day simple moving average of $14.89 and a 200 day simple moving average of $14.91. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $15.80.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be given a $0.11 dividend. This represents a c) annualized dividend and a dividend yield of 9.4%. The ex-dividend date of this dividend is Monday, June 15th.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Hedge funds have recently made changes to their positions in the company. Kestra Advisory Services LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the 4th quarter valued at $26,000. Geneos Wealth Management Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust in the first quarter worth $40,000. Allworth Financial LP raised its holdings in shares of BlackRock Health Sciences Term Trust by 24,584.6% during the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after acquiring an additional 3,196 shares in the last quarter. CWM LLC boosted its position in BlackRock Health Sciences Term Trust by 25.6% during the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares during the last quarter. Finally, Newbridge Financial Services Group Inc. purchased a new position in BlackRock Health Sciences Term Trust in the second quarter valued at about $69,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.